Hillhouse Capital Management - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hillhouse Capital Management ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2017$6,609,000
-16.0%
944,202
+4.9%
0.11%
-13.8%
Q3 2017$7,866,000
-4.1%
900,0000.0%0.13%
+3.2%
Q2 2017$8,199,000
+20.8%
900,000
+5.3%
0.13%
-4.5%
Q1 2017$6,788,000
+26.5%
854,900
+42.5%
0.13%
+10.0%
Q4 2016$5,364,000
-48.5%
600,0000.0%0.12%
-43.7%
Q3 2016$10,410,000
+147.5%
600,0000.0%0.21%
+100.9%
Q2 2016$4,206,000600,0000.11%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders